Factor H and properdin recognize different epitopes on renal tubular epithelial heparan sulfate

Journal of Biological Chemistry

Volumn 287, Issue 37, 2012, Pages 31471-31481

  Zaferani, Azadeh ^a   Vivès, Romain R ^b   Van Der Pol, Pieter ^c   Navis, Gerjan J ^a   Daha, Mohamed R ^a,c   Van Kooten, Cees ^c   Lortat Jacob, Hugues ^b   Seelen, Marc A ^a   Van Den Born, Jacob ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b CNRS   (France)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EPITHELIAL CELLS; GLYCOSAMINOGLYCANS; H-BINDING; HEPARAN SULFATES; HIGH AFFINITY; IN-VITRO; NONOVERLAPPING; PRE-INCUBATION; PRE-TREATMENT; RENAL DISEASE; RENAL TISSUE; SERUM PROTEINS; TUBULAR CELLS;

CELLS; POLYSACCHARIDES; TISSUE;

ANTIGENS;

COMPLEMENT FACTOR H; EPITOPE; GLYCOSAMINOGLYCAN; HEPARAN SULFATE; HEPARINOID; POLYSACCHARIDE; PROPERDIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; EPITHELIUM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; INCUBATION TIME; KIDNEY PARENCHYMA; KIDNEY TUBULE CELL; KIDNEY TUBULE EPITHELIUM; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEINURIA; PROXIMAL TUBULAR EPITHELIAL CELL; RAT; SULFATION; SURFACE PLASMON RESONANCE;

ANIMALS; CELL LINE; COMPLEMENT FACTOR H; EPITOPES; HEPARITIN SULFATE; HUMANS; KIDNEY TUBULES; MALE; PROPERDIN; PROTEIN BINDING; PROTEINURIA; RATS; RATS, WISTAR;

EID: 84866133160     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M112.380386     Document Type: Article

References (49)

1. Berger, S. P., Roos, A., and Daha, M. R. (2005) Complement and the kidney. What the nephrologist needs to know in 2006? Nephrol. Dial. Transplant. 20, 2613-2619
2. Vieyra, M. B., and Heeger, P. S. (2010) Novel aspects of complement in kidney injury. Kidney Int. 77, 495-499
3. Abbate, M., Zoja, C., Corna, D., Rottoli, D., Zanchi, C., Azzollini, N., Tomasoni, S., Berlingeri, S., Noris, M., Morigi, M., and Remuzzi, G. (2008) Complement-mediated dysfunction of glomerular filtration barrier accelerates progressive renal injury. J. Am. Soc. Nephrol. 19, 1158-1167
4. Buelli, S., Abbate, M., Morigi, M., Moioli, D., Zanchi, C., Noris, M., Zoja, C., Pusey, C. D., Zipfel, P. F., and Remuzzi, G. (2009) Protein load impairs factor H binding promoting complement-dependent dysfunction of proximal tubular cells. Kidney Int. 75, 1050-1059
5. Zipfel, P. F., Heinen, S., Józsi, M., and Skerka, C. (2006) Complement and diseases. Defective alternative pathway control results in kidney and eye diseases. Mol. Immunol. 43, 97-106
6. Pangburn, M. K. (2000) Host recognition and target differentiation by factor H, a regulator of the alternative pathway of complement. Immunopharmacology. 49, 149-157
7. Ferreira, V. P., Pangburn, M. K., and Cortés, C. (2010) Complement control protein factor H. The good, the bad, and the inadequate. Mol. Immunol. 47, 2187-2197
8. Aslam, M., and Perkins, S. J. (2001) Folded-back solution structure of monomeric factor H of human complement by synchrotron x-ray and neutron scattering, analytical ultracentrifugation and constrained molecular modelling. J. Mol. Biol. 309, 1117-1138
9. Jokiranta, T. S., Hellwage, J., Koistinen, V., Zipfel, P. F., and Meri, S. (2000) Each of the three binding sites on complement factor H interacts with a distinct site on C3b. J. Biol. Chem. 275, 27657-27662
10. Schmidt, C. Q., Herbert, A. P., Kavanagh, D., Gandy, C., Fenton, C. J., Blaum, B. S., Lyon, M., Uhrín, D., and Barlow, P. N. (2008) A new map of glycosaminoglycan and C3b binding sites on factor H. J. Immunol. 181, 2610-2619
11. Esko, J. D., and Lindahl, U. (2001) Molecular diversity of heparan sulfate. J. Clin. Invest. 108, 169-173
12. Rienstra, H., Katta, K., Celie, J. W., van Goor, H., Navis, G., van den Born, J., and Hillebrands, J. L. (2010) Differential expression of proteoglycans in tissue remodeling and lymphangiogenesis after experimental renal transplantation in rats. PLoS One 5, e9095
13. Bishop, J. R., Schuksz, M., and Esko, J. D. (2007) Heparan sulphate proteoglycans fine-tune mammalian physiology. Nature 446, 1030-1037
14. Whitelock, J. M., and Iozzo, R. V. (2005) Heparan sulfate. A complex polymer charged with biological activity. Chem. Rev. 105, 2745-2764
15. Maillet, F., Petitou, M., Choay, J., and Kazatchkine, M. D. (1988) Structure-function relationships in the inhibitory effect of heparin on complement activation. Independency of the anti-coagulant and anti-complementary sites on the heparin molecule. Mol. Immunol. 25, 917-923
16. Maillet, F., Kazatchkine, M. D., Glotz, D., Fischer, E., and Rowe, M. (1983) Heparin prevents formation of the human C3 amplification convertase by inhibiting the binding site for B on C3b. Mol. Immunol. 20, 1401-1404
17. Zaferani, A., Vivès, R. R., van der Pol, P., Hakvoort, J. J., Navis, G. J., van Goor, H., Daha, M. R., Lortat-Jacob, H., Seelen, M. A., and van den Born, J. (2011) Identification of tubular heparan sulfate as a docking platform for the alternative complement component properdin in proteinuric renal disease. J. Biol. Chem. 286, 5359-5367
18. Kirschfink, M., Blase, L., Engelmann, S., and Schwartz-Albiez, R. (1997) Secreted chondroitin sulfate proteoglycan of human B cell lines binds to the complement protein C1q and inhibits complex formation of C1. J. Immunol. 158, 1324-1331
19. Yu, H., Muñoz, E. M., Edens, R. E., and Linhardt, R. J. (2005) Kinetic studies on the interactions of heparin and complement proteins using surface plasmon resonance. Biochim. Biophys. Acta 1726, 168-176
20. Rook, M., Lely, A. T., Kramer, A. B., van Goor, H., and Navis, G. (2005) Individual differences in renal ACE activity in healthy rats predict susceptibility to adriamycin-induced renal damage. Nephrol. Dial. Transplant. 20, 59-64
21. van Timmeren, M. M., Bakker, S. J., Vaidya, V. S., Bailly, V., Schuurs, T. A., Damman, J., Stegeman, C. A., Bonventre, J. V., and van Goor, H. (2006) Tubular kidney injury molecule-1 in protein-overload nephropathy. Am. J. Physiol. Renal Physiol. 291, F456-F464
22. Daha, M. R., and van Es, L. A. (1982) Isolation, characterization, and mechanism of action of rat β1H. J. Immunol. 128, 1839-1843
23. Gaarkeuken, H., Siezenga, M. A., Zuidwijk, K., van Kooten, C., Rabelink, T. J., Daha, M. R., and Berger, S. P. (2008) Complement activation by tubular cells is mediated by properdin binding. Am. J. Physiol. Renal Physiol. 295, F1397-F403
24. Weiler, J. M., Daha, M. R., Austen, K. F., and Fearon, D. T. (1976) Control of the amplification convertase of complement by the plasma protein β1H. Proc. Natl. Acad. Sci. U.S.A. 73, 3268-3272
25. Brooimans, R. A., Hiemstra, P. S., van der Ark, A. A., Sim, R. B., van Es, L. A., and Daha, M. R. (1989) Biosynthesis of complement factor H by human umbilical vein endothelial cells. Regulation by T cell growth factor and IFN-γ. J. Immunol. 142, 2024-2030
26. Sadir, R., Forest, E., and Lortat-Jacob, H. (1998) The heparan sulfate binding sequence of interferon-γ increased the on rate of the interferon-γ-interferon-γ receptor complex formation. J. Biol. Chem. 273, 10919-10925
27. Vann, W. F., Schmidt, M. A., Jann, B., and Jann, K. (1981) The structure of the capsular polysaccharide (K5 antigen) of urinary-tract-infective Escherichia coli 010:K5:H4. A polymer similar to desulfo-heparin. Eur. J. Biochem. 116, 359-364
28. Iverius, P. (1971) Coupling of glycosaminoglycans to agarose beads (Sepharose 4B). Biochem. J. 124, 677-683
29. Bäckström, G., Höök, M., Lindahl, U., Feingold, D. S., Malmström, A., Rodén, L., and Jacobsson, I. (1979) Biosynthesis of heparin. Assay and properties of the microsomal uronosyl C-5 epimerase. J. Biol. Chem. 254, 2975-2982
30. Rej, R. N., Ludwig-Baxter, K. G., and Perlin, A. S. (1991) Sulfation of some chemically-modified heparins. Formation of a 3-sulfate analog of heparin. Carbohydr. Res. 210, 299-310
31. van den Born, J., Gunnarsson, K., Bakker, M. A., Kjellén, L., Kusche-Gullberg, M., Maccarana, M., Berden, J. H., and Lindahl, U. (1995) Presence of N-unsubstituted glucosamine units in native heparan sulfate revealed by a monoclonal antibody. J. Biol. Chem. 270, 31303-31309
32. Vivès, R. R., Sadir, R., Imberty, A., Rencurosi, A., and Lortat-Jacob, H. (2002) A kinetics and modeling study of RANTES(9-68) binding to heparin reveals a mechanism of cooperative oligomerization. Biochemistry 41, 14779-14789
33. Onda, K., Ohsawa, I., Ohi, H., Tamano, M., Mano, S., Wakabayashi, M., Toki, A., Horikoshi, S., Fujita, T., and Tomino, Y. (2011) Excretion of complement proteins and its activation marker C5b-9 in IgA nephropathy in relation to renal function. BMC Nephrol. 12, 64
34. Tamano, M., Fuke, Y., Endo, M., Ohsawa, I., Fujita, T., and Ohi, H. (2002) Urinary complement factor H in renal disease. Nephron. 92, 705-707
35. Zhang, J. J., Jiang, L., Liu, G., Wang, S. X., Zou, W. Z., Zhang, H., and Zhao, M. H. (2009) Levels of urinary complement factor H in patients with IgA nephropathy are closely associated with disease activity. Scand. J. Immunol. 69, 457-464
36. van den Born, J., Salmivirta, K., Henttinen, T., Ostman, N., Ishimaru, T., Miyaura, S., Yoshida, K., and Salmivirta, M. (2005) Novel heparan sulfate structures revealed by monoclonal antibodies. J. Biol. Chem. 280, 20516-20523
37. Borgenström, M., Wärri, A., Hiilesvuo, K., Käkönen, R., Käkönen, S., Nissinen, L., Pihlavisto, M., Marjamäki, A., Vlodavsky, I., Naggi, A., Torri, G., Casu, B., Veromaa, T., Salmivirta, M., and Elenius, K. (2007)O-Sulfated bacterial polysaccharides with low anticoagulant activity inhibit metastasis. Semin. Thromb. Hemost. 33, 547-556
38. Kelly, U., Yu, L., Kumar, P., Ding, J. D., Jiang, H., Hageman, G. S., Arshavsky, V. Y., Frank, M. M., Hauser, M. A., and Rickman, C. B. (2010) Heparan sulfate, including that in Bruch's membrane, inhibits the complement alternative pathway. Implications for age-related macular degeneration. J. Immunol. 185, 5486-5494
39. Clark, S. J., Perveen, R., Hakobyan, S., Morgan, B. P., Sim, R. B., Bishop, P. N., and Day, A. J. (2010) Impaired binding of the age-related macular degeneration-associated complement factor H 402H allotype to Bruch's membrane in human retina. J. Biol. Chem. 285, 30192-30202
40. Lehtinen, M. J., Rops, A. L., Isenman, D. E., van der Vlag, J., and Jokiranta, T. S. (2009) Mutations of factor H impair regulation of surface-bound C3b by three mechanisms in atypical hemolytic uremic syndrome. J. Biol. Chem. 284, 15650-15658
41. Abbate, M., Zoja, C., and Remuzzi, G. (2006) How does proteinuria cause progressive renal damage? J. Am. Soc. Nephrol. 17, 2974-2984
42. Siezenga, M. A., van der Geest, R. N., Mallat, M. J., Rabelink, T. J., Daha, M. R., and Berger, S. P. (2010) Urinary properdin excretion is associated with intrarenal complement activation and poor renal function. Nephrol. Dial. Transplant. 25, 1157-1161
43. Lenderink, A. M., Liegel, K., Ljubanovi, D., Coleman, K. E., Gilkeson, G. S., Holers, V. M., and Thurman, J. M. (2007) The alternative pathway of complement is activated in the glomeruli and tubulointerstitium of mice with adriamycin nephropathy. Am. J. Physiol. Renal Physiol. 293, F555-F564
44. Renner, B., Ferreira, V. P., Cortes, C., Goldberg, R., Ljubanovic, D., Pangburn, M. K., Pickering, M. C., Tomlinson, S., Holland-Neidermyer, A., Strassheim, D., Holers, V. M., and Thurman, J. M. (2011) Binding of factor H to tubular epithelial cells limits interstitial complement activation in ischemic injury. Kidney Int. 80, 165-173
45. He, C., Imai, M., Song, H., Quigg, R. J., and Tomlinson, S. (2005) Complement inhibitors targeted to the proximal tubule prevent injury in experimental nephrotic syndrome and demonstrate a key role for C5b-9. J. Immunol. 174, 5750-5757
46. Celie, J. W., Katta, K. K., Adepu, S., Melenhorst, W. B., Reijmers, R. M., Slot, E. M., Beelen, R. H., Spaargaren, M., Ploeg, R. J., Navis, G., van der Heide, J. J., van Dijk, M. C., van Goor, H., and van den Born, J. (2012) Tubular epithelial syndecan-1 maintains renal function in murine ischemia/reperfusion and human transplantation. Kidney Int. 81, 651-661
47. Weiler, J. M., Edens, R. E., Linhardt, R. J., and Kapelanski, D. P. (1992) Heparin and modified heparin inhibit complement activation in vivo. J. Immunol. 148, 3210-3215
48. Blondin, C., Fischer, E., Boisson-Vidal, C., Kazatchkine, M. D., and Jozefonvicz, J. (1994) Inhibition of complement activation by natural sulfated polysaccharides (fucans) from brown seaweed. Mol. Immunol. 31, 247-253
49. Türk, H., Haag, R., and Alban, S. (2004) Dendritic polyglycerol sulfates as new heparin analogues and potent inhibitors of the complement system. Bioconjug. Chem. 15, 162-167